title: Safe administration of intravenous iron therapy.
abstract: This article describes the process of setting up a community service to meet the needs of patients with chronic kidney disease who have iron-deficiency anaemia. The service provides a course of intravenous (IV) iron therapy, which is usually given initially weekly for five weeks. Collaboration between specialist anaemia services in secondary care and the community IV therapy team in Liverpool aimed to develop a safe, patient-centred service. This service and the development of new medications has made the delivery of IV iron therapy in the community possible.
authors: Community Intravenous Therapy Team, Liverpool. Shirley.Smith@LiverpoolCH.nhs.uk
authors: Shirley
authors: S
authors: Smith
mesh_terms: D018798:Anemia, Iron-Deficiency / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage* / Q000627:therapeutic use; D012308:Risk Management
chemical_list: D007501:Iron